Fludarabine phosphate and Demyelination - a phase IV clinical study of FDA data

Summary:

Demyelination is reported as a side effect among people who take Fludarabine phosphate (fludarabine phosphate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Cyclophosphamide, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Demyelination when taking Fludarabine phosphate. It is created by eHealthMe based on reports of 12,833 people who have side effects when taking Fludarabine phosphate from the FDA, and is updated regularly.

What is Fludarabine phosphate?

Fludarabine phosphate has active ingredients of fludarabine phosphate. eHealthMe is studying from 12,840 Fludarabine phosphate users. Check the latest studies of Fludarabine phosphate.

What is Demyelination?

Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function) is found to be associated with 458 drugs and 670 conditions by eHealthMe. Check the latest studies of Demyelination.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

12,833 people reported to have side effects when taking Fludarabine phosphate.
Among them, 22 people (0.17%) have Demyelination.

Could Fludarabine phosphate cause Demyelination?

Among these 22 people:

How long have people been on Fludarabine phosphate when they have Demyelination? *

What is the gender of people who have Demyelination when taking Fludarabine phosphate? *

female: 30 %
male: 70 %

What is the age of people who have Demyelination when taking Fludarabine phosphate? *

What are other drugs people take besides Fludarabine phosphate? *

What are other side effects people have besides Demyelination? *

Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 10 people, 45.45%
Jc Virus Infection: 9 people, 40.91%
Blindness: 7 people, 31.82%
Drowsiness: 4 people, 18.18%
Dizziness: 4 people, 18.18%
Incontinence (lack of moderation or self-control): 4 people, 18.18%
Muscle Twitching: 3 people, 13.64%
Multi-Organ Failure (multisystem organ failure): 3 people, 13.64%
Optic Atrophy (the loss of a proportion of optic disc nerve fibres): 3 people, 13.64%
Mood Swings (an extreme or rapid change in mood): 3 people, 13.64%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 10 people, 45.45%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 9.09%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 4.55%
Lymphoma (cancer that begins in immune system cells): 1 person, 4.55%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 4.55%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 4.55%
Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 1 person, 4.55%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Fludarabine phosphate and have Demyelination?

- Check whether Demyelination is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fludarabine phosphate:

Fludarabine phosphate (12,840 reports)

Demyelination treatments and more:

Demyelination (5,739 reports)

Browse all side effects of Fludarabine phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Demyelination:

Demyelination (458 drugs)

Browse all the conditions that are associated with Demyelination:

Demyelination (670 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fludarabine phosphate (the active ingredients of Fludarabine phosphate) and Fludarabine phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.